ArticleChina CDC weekly2020
Epidemiological Characteristics of Newly Diagnosed Cases of HIV through Injection Drug Use - China, 2012-2019.
Article in China CDC weekly, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Characterizing HIV-1 transmission by genetic cluster analysis among newly diagnosed patients in the China-Myanmar border region from 2020 to 2023.Emerging microbes & infections · 2024Article
- Behavioral verification and risk factors of HIV cross-population transmission in China: analysis of national surveillance data 1989-2022.BMC infectious diseases · 2024Article
- Transmission network and phylogenetic analysis reveal older male-centered transmission of CRF01_AE and CRF07_BC in Guangxi, China.Emerging microbes & infections · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The annual rates of newly diagnosed cases of human immunodeficiency virus (HIV) are increasing in China, yet the annual number of newly diagnosed cases of HIV infected through injection drug use (IDU) is decreasing. Newly diagnosed cases of HIV infected through IDU in China from 2012 to 2019 show decreases year over year, but the risk of new infections through injecting drugs still exists. This study highlighted that new HIV infections through IDU continue to be at a low level. However, individuals that are newly diagnosed as HIV-positive through IDU need to have their baseline CD4 T+ lymphocytes (CD4) cell counts monitored and have their sources of infections traced.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.